BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 29661714)

  • 21. Amyloid A4 protein and its precursor in Down's syndrome and Alzheimer's disease.
    Rumble B; Retallack R; Hilbich C; Simms G; Multhaup G; Martins R; Hockey A; Montgomery P; Beyreuther K; Masters CL
    N Engl J Med; 1989 Jun; 320(22):1446-52. PubMed ID: 2566117
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term intracerebral transplants of fetal hippocampus from mouse trisomy 16, a model for Down's syndrome (trisomy 21), do not exhibit Alzheimer's disease neuropathology by ultrastructural criteria .
    Lane NJ; Balbo A; Stoll J; Rapoport SI
    Tissue Cell; 1994 Aug; 26(4):477-88. PubMed ID: 8091421
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Topographic relationship between neurofibrillary change and acetylcholinesterase rich neurons in the upper brain stem of patients with senile dementia of the Alzheimer's type and Down's syndrome.
    Shortridge BA; Vogel FS; Burger PC
    Clin Neuropathol; 1985; 4(6):227-37. PubMed ID: 2934202
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Topography of neurofibrillary tangles and granulovacuoles in hippocampi of patients with Down's syndrome: quantitative comparison with normal ageing and Alzheimer's disease.
    Ball MJ; Nuttall K
    Neuropathol Appl Neurobiol; 1981; 7(1):13-20. PubMed ID: 6453301
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Down's syndrome and its association with Alzheimer's disease.
    Yatham LN; McHale PA; Kinsella A
    Acta Psychiatr Scand; 1988 Jan; 77(1):38-41. PubMed ID: 2964773
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intersectin 1 contributes to phenotypes in vivo: implications for Down's syndrome.
    Hunter MP; Nelson M; Kurzer M; Wang X; Kryscio RJ; Head E; Pinna G; O'Bryan JP
    Neuroreport; 2011 Oct; 22(15):767-72. PubMed ID: 21876463
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alzheimer's disease, Down's syndrome, and aging: the genetic approach.
    Sinex FM; Myers RH
    Ann N Y Acad Sci; 1982; 396():3-13. PubMed ID: 6217775
    [No Abstract]   [Full Text] [Related]  

  • 28. The link between Down's syndrome and Alzheimer's disease: 1.
    Soliman A; Hawkins D
    Br J Nurs; 1998 Jul 9-22; 7(13):779-84. PubMed ID: 9732570
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Cytogenetic study and chromosome abnormalities of Alzheimer's disease and Down's syndrome].
    Asaka A
    Nihon Rinsho; 1988 Jul; 46(7):1502-7. PubMed ID: 2975715
    [No Abstract]   [Full Text] [Related]  

  • 30. Down's syndrome and Alzheimer's disease: a review.
    Oliver C; Holland AJ
    Psychol Med; 1986 May; 16(2):307-22. PubMed ID: 2941815
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The link between Down's syndrome and Alzheimer's disease: 2.
    Soliman A; Hawkins D
    Br J Nurs; 1998 Jul 23-Aug 12; 7(14):847-50. PubMed ID: 9849146
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Alzheimer's disease and Down's syndrome: a review].
    Vicari S; Caltagirone C
    Riv Neurol; 1990; 60(4):151-9. PubMed ID: 2151240
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased expression of importin-β, exportin-5 and nuclear transportable proteins in Alzheimer's disease aids anatomic pathologists in its diagnosis.
    Nuovo G; Amann V; Williams J; Vandiver P; Quinonez M; Fadda P; Paniccia B; Mezache L; Mikhail A
    Ann Diagn Pathol; 2018 Feb; 32():10-16. PubMed ID: 29414391
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Memantine for dementia in adults older than 40 years with Down's syndrome (MEADOWS): a randomised, double-blind, placebo-controlled trial.
    Hanney M; Prasher V; Williams N; Jones EL; Aarsland D; Corbett A; Lawrence D; Yu LM; Tyrer S; Francis PT; Johnson T; Bullock R; Ballard C;
    Lancet; 2012 Feb; 379(9815):528-36. PubMed ID: 22236802
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alzheimer's disease and senile dementia: genetic relationships to Down's syndrome and hematologic cancer.
    Heston LL
    Res Publ Assoc Res Nerv Ment Dis; 1979; 57():167-76. PubMed ID: 154163
    [No Abstract]   [Full Text] [Related]  

  • 36. Prenatal pharmacotherapy rescues brain development in a Down's syndrome mouse model.
    Guidi S; Stagni F; Bianchi P; Ciani E; Giacomini A; De Franceschi M; Moldrich R; Kurniawan N; Mardon K; Giuliani A; Calzà L; Bartesaghi R
    Brain; 2014 Feb; 137(Pt 2):380-401. PubMed ID: 24334313
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuronal overexpression of Alzheimer's disease and Down's syndrome associated DYRK1A/minibrain gene alters motor decline, neurodegeneration and synaptic plasticity in Drosophila.
    Lowe SA; Usowicz MM; Hodge JJL
    Neurobiol Dis; 2019 May; 125():107-114. PubMed ID: 30703437
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Levels of phospholipid catabolic intermediates, glycerophosphocholine and glycerophosphoethanolamine, are elevated in brains of Alzheimer's disease but not of Down's syndrome patients.
    Blusztajn JK; Lopez Gonzalez-Coviella I; Logue M; Growdon JH; Wurtman RJ
    Brain Res; 1990 Dec; 536(1-2):240-4. PubMed ID: 2150771
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Apolipoprotein E epsilon 2 allele promotes longevity and protects patients with Down's syndrome from dementia.
    Royston MC; Mann D; Pickering-Brown S; Owen F; Perry R; Raghavan R; Khin-Nu C; Tyrer S; Day K; Crook R
    Neuroreport; 1994 Dec; 5(18):2583-5. PubMed ID: 7696609
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A case of Down's syndrome with diffuse Lewy body disease and Alzheimer's disease.
    Bodhireddy S; Dickson DW; Mattiace L; Weidenheim KM
    Neurology; 1994 Jan; 44(1):159-61. PubMed ID: 8290054
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.